INIS
lymphomas
100%
ploidy
100%
patients
66%
dna
66%
paraffin
66%
clinical trials
33%
therapy
33%
risks
33%
information
33%
performance
33%
variations
33%
biopsy
33%
multivariate analysis
33%
indicators
33%
nuclei
33%
aneuploidy
33%
lactate dehydrogenase
33%
mitotic index
33%
Medicine and Dentistry
Non-Hodgkin Lymphoma
100%
Ploidy
100%
Survival
100%
S Phase
80%
Specimen
40%
Paraffin
40%
Analysis
40%
Patient
40%
Biological Product
20%
Aneuploidy
20%
DNA
20%
Combination Therapy
20%
Clinical Feature
20%
Multivariate Analysis
20%
Flow Cytometry
20%
Cell DNA
20%
Lactate Dehydrogenase
20%
Mitotic Index
20%
Age
20%
Indicator
20%
Biopsy
20%
Prognosis
20%
Nursing and Health Professions
Nonhodgkin Lymphoma
100%
Survival
100%
Ploidy
100%
Paraffin
40%
Analysis
40%
Flow
40%
Biological Product
20%
Clinical Outcome
20%
Biopsy
20%
Prognosis
20%
Multivariate Analysis
20%
Clinical Feature
20%
Combination Therapy
20%
DNA
20%
Aneuploidy
20%
Flow Cytometry
20%
Lactate Dehydrogenase
20%
Parameters
20%
Indicator
20%
Mitosis Index
20%
Cell DNA
20%
DNA Content
20%
Biochemistry, Genetics and Molecular Biology
Ploidy
100%
Survival
100%
S Phase
80%
Flow
40%
Aneuploidy
20%
Lactate Dehydrogenase
20%
Flow Cytometry
20%
DNA Content
20%
Age
20%
Mitosis Index
20%
Clinical Trial
20%
DNA
20%
Multivariate Analysis
20%
Neuroscience
Ploidy
100%
Non-Hodgkin Lymphoma
100%
Predictor
66%
DNA
33%
Flow Cytometry
33%
Cell DNA
33%
Lactate Dehydrogenase
33%
Mitosis Index
33%
Behavior (Neuroscience)
33%
Pharmacology, Toxicology and Pharmaceutical Science
Nonhodgkin Lymphoma
100%
Survival
100%
Paraffin
40%
DNA
20%
Prognosis
20%
Biological Product
20%
Clinical Feature
20%
Lactate Dehydrogenase
20%
Flow Cytometry
20%
Cell DNA
20%
Indicator
20%
Aneuploidy
20%